1. Home
  2. SWAG vs EVAX Comparison

SWAG vs EVAX Comparison

Compare SWAG & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

N/A

Current Price

$1.70

Market Cap

38.2M

ML Signal

N/A

EVAX

Evaxion Biotech

N/A

Current Price

$3.80

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWAG
EVAX
Founded
1994
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
31.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SWAG
EVAX
Price
$1.70
$3.80
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
30.7K
32.1K
Earning Date
03-27-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$1.20
52 Week High
$3.50
$12.15

Technical Indicators

Market Signals
Indicator
SWAG
EVAX
Relative Strength Index (RSI) 45.03 49.34
Support Level $1.64 $2.45
Resistance Level $1.89 $4.64
Average True Range (ATR) 0.11 0.40
MACD -0.00 0.04
Stochastic Oscillator 44.83 38.48

Price Performance

Historical Comparison
SWAG
EVAX

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: